Results can be enhanced with repeated sessions according to your customized plan
Although both treatments are highly effective, they work differently in the body and may lead to different outcomes in terms of weight loss, side effects, and cost
Heart failure When compared to placebo, GLP-1 RAs showed a non-significant reduction in heart failure in CKD (RR 0.90, 95% CI 0.601.33
To maximize the therapeutic benefit of CLO, the exact dosage, delivery method, and pharmacokinetic studies should be carefully considered and studied through clinical trials
The relevance to humans remains uncertain, as human thyroid C-cells express far fewer GLP-1 receptors than rodent C-cells
#Pharmacy #DrugSafety #CDSCO #PatientSafety #Pharmacovigilance #EvidenceBasedMedicine #Healthcare #RegulatoryAffairs #FixedDoseCombination #PublicHealth #PharmaProfessionals To view or add a comment, sign in Regulatory Update: India Bans 16 Fixed-Dose Combination (FDC) Drugs In a significant move to strengthen patient safety and promote the rational use of medicines, the Government of India has prohibited the manufacture, sale, and distribution of 16 Fixed-Dose Combination (FDC) drugs with immediate effect
